← Back to the wire

Danish Central Bank Doubles Growth Forecast on Novo’s US Boom

Macro·1 article across 1 outlet

Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data

Denmark’s central bank more than doubled its growth forecast for this year as surging US sales and production at Novo Nordisk A/S fuel strong exports in the Nordic country’s pharmaceutical industry.

The increase in the growth forecast reflects the significant impact of Novo Nordisk's performance on the Danish economy, particularly in the pharmaceutical sector.

Novo Nordisk

Sources

Every quote below is verbatim from the article it is attributed to.

SourceReports the news
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.